Bernd Dölle, Ph.D.

Bernd Dölle, Ph.D - Aseptic Manufacturing, PDA/FDA, Barrier Technology, Lyophilization and Sterile Crystallization Specialist

Aseptic Manufacturing, PDA/FDA, Barrier Technology Specialist

 

 

Bernd Dölle, Ph.D.,
Senior Consultant

Qualifications

Over twenty five years broad ranging pharmaceutical industrial experience as a Qualified Person with extensive management responsibilities for synthetic and biological activities, parenteral, oral and over the counter drugs. Skills range broadly, covering areas such as plant design, plant start-up, optimization of plant operations, personnel training, submission and maintenance of regulatory filings, qualification of contract manufacturers. Extensive experience with EU and FDA inspections.

2008 - Present
Senior Consultant
D.H. Gold Associates, Inc.
   

Specializing in conceptual plant design and start-up, staff training, compliance, evaluation and remediation, operational optimization and European filings.

2001 - 2008
Vice President Technical Operations

Merz Pharma GmbH & Co. KGaA

   

Responsible for management of the Merz Reinheim, Oldenwald and Dessau plants. Total 160 FTEs. Responsibilities included In-house and Contract Manufacturing, Engineering, Total Quality Management, Technical Services, Quality Control, Environmental Protection and Operational Safety. Conducted extensive GMP upgrades of the Reinheim drug product plant. Developed design concepts, implemented engineering and construction oversight for a new very high potency biologic API and parenteral manufacturing drug product plant in Dessau using isolator technology, approved by EU authorities in 2009, FDA in 2010.

1982 - 2000
Head of Pharmaceutical Production
ASTA Medica AG
   

Increasingly responsible positions, culminating as Head of Pharmaceutical Production, responsible for production at the Künsebeck and Dresden locations, producing oral, inhalation and sterile dosage products. At the corporate level was responsible for production oversight at eight world-wide locations. Responsible for management of a new facility using isolator technology for production of cytostatics from the APIs to the finished parenteral dosage products.

 

 

Education

 

  1977 - 1981

Ph.D. (Pharmaceutical Technology)

Friedrich-Alexander-University, Erlangen
  1979 Pharmacist License
  1973 - 1997

Pharmacy Degree

Friedrich-Alexander-University, Erlangen


 

 

Home | The Consulting Team | Consulting Services | Contact DHG | Why Choose DHG? | Our Success Stories | DHG Compliance Training | 483 Recovery


Website by eBiz ROI, Inc.
[Close Box]

D.H.Gold Associates, Inc. - Consultants

D.H.Gold Associates, Inc. has assembled well skilled professionals to complement Dr. Gold’s background.  Detailed CV’s of each associates are available by following the links below:

 

Daniel H. Gold, Ph.D. - President & CEO

Stanley Alekman, Ph.D. - Analytical Chemistry & Statistics Specialist

William Bennett, M.S., B.S. - Engineering & Manufacturing Specialist

Bao-Shan Huang, Ph.D. - Process Development, Analytical Laboratory Control Specialist

Jeanne Moldenhauer, M.S. - Microbiology Specialist

Eugene Rynkowski, M.S. - Analytical Chemistry Specialist

Eric Sheinin, Ph.D. - Specialist in CMC Sections of NDA, ANDA & DMF Filings

James Shaver, B.S., B.Ch.E - Engineering & Operational Management Specialist

Bernd Dölle, Ph.D. - Aseptic Manufacturing, PDA/FDA Barrier Technology Specialist

Takeo Murakawa, Ph.D. - Drug Development & Regulatory Affairs Specialist

Thomas Murphy, M.S. - Industrial Statistical Consultant

 

DHG Consulting Team with a total of 195+ years in the Pharmaceutical Industry.

 

Website by eBiz ROI, Inc.